Parents' perception of their children's process of reintegration after childhood cancer treatment.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 30 01 2020
accepted: 16 09 2020
entrez: 1 10 2020
pubmed: 2 10 2020
medline: 1 12 2020
Statut: epublish

Résumé

Our objective was to further the understanding of the process of reintegration of childhood cancer patients after treatment and to identify factors influencing that process. Using a qualitative approach, we conducted 49 interviews with parents (n = 29 mothers, n = 20 fathers) from 31 families with a child (<18 years) with leukemia or CNS tumor. Interviews were conducted about 16 to 24 months after the end of the treatment. We used a semi-structured interview guideline and analyzed the data using content analysis. Average age of pediatric cancer patients was 5.5 years at the time of diagnosis; mean time since diagnosis was 3.5 years. Parents reported immediate impact of the disease on their children. Reintegration had gone along with delayed nursery/school enrollment or social challenges. In most cases reintegration was organized with a gradual increase of attendance. Due to exhaustion by obligatory activities, reintegration in leisure time activities was demanding and parents reported a gradual increase of activity level for their children. Parents described several barriers and facilitators influencing the reintegration process into nursery/school and leisure time activities (structural support, social support, health status, intrapersonal aspects). Although many children reintegrate well, the process takes lots of effort from parents and children. Childhood cancer survivors and their families should be supported after the end of intensive treatment to facilitate reintegration.

Identifiants

pubmed: 33002084
doi: 10.1371/journal.pone.0239967
pii: PONE-D-20-01993
pmc: PMC7529258
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0239967

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Psychooncology. 2019 Apr;28(4):847-853
pubmed: 30758107
J Pediatr Oncol Nurs. 2019 Jan/Feb;36(1):55-68
pubmed: 30406714
Psychooncology. 2012 Jul;21(7):685-94
pubmed: 22006640
Eur J Cancer Care (Engl). 2018 Nov;27(6):e12661
pubmed: 28169481
Support Care Cancer. 2010 Dec;18(12):1499-513
pubmed: 20680353
Eur J Cancer. 2015 Jul;51(10):1203-11
pubmed: 25958037
BMJ Open. 2020 Mar 8;10(3):e033730
pubmed: 32152163
Psychooncology. 2014 Oct;23(10):1157-64
pubmed: 24817624
Cancer. 2005 Oct 15;104(8):1751-60
pubmed: 16130127
Pediatr Blood Cancer. 2018 Aug;65(8):e27109
pubmed: 29697192
J Health Psychol. 2019 Sep;24(10):1436-1447
pubmed: 28988492
Pediatr Neurol. 2011 Jan;44(1):21-30
pubmed: 21147383
Eur J Cancer Care (Engl). 2016 Jan;25(1):170-9
pubmed: 25204197
Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S514-84
pubmed: 26700918
Lancet. 2017 Dec 9;390(10112):2569-2582
pubmed: 28890157
J Pediatr Oncol Nurs. 2018 Mar/Apr;35(2):118-131
pubmed: 29192538
J Pediatr Oncol Nurs. 2004 May-Jun;21(3):165-9
pubmed: 15296047
J Clin Oncol. 2009 May 10;27(14):2390-5
pubmed: 19224833
Eur J Cancer Care (Engl). 2011 Mar;20(2):163-9
pubmed: 20345458
Pediatrics. 2019 May 20;:
pubmed: 31110166
Br J Cancer. 2013 Sep 3;109(5):1373-81
pubmed: 23880828
Annu Rev Public Health. 2007;28:279-302
pubmed: 17367288
Pediatr Blood Cancer. 2016 Apr;63(4):737-9
pubmed: 26681662
J Clin Oncol. 2018 Jul 20;36(21):2190-2197
pubmed: 29874134
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Pediatr Blood Cancer. 2013 Apr;60(4):543-9
pubmed: 23281199
J Pediatr Oncol Nurs. 2008 Nov-Dec;25(6):331-9
pubmed: 18812587
Pediatrics. 2009 Mar;123(3):906-15
pubmed: 19255020
Neuropediatrics. 2005 Dec;36(6):357-65
pubmed: 16429375
BMJ. 2013 Mar 27;346:f1190
pubmed: 23535255
Pediatr Blood Cancer. 2019 Mar;66(3):e27530
pubmed: 30426663
Support Care Cancer. 2019 Nov;27(11):4341-4351
pubmed: 30900055
Psychooncology. 2015 Feb;24(2):204-11
pubmed: 24906202
Eur J Cancer. 2018 Oct;102:69-81
pubmed: 30138773
BMJ Open. 2017 Aug 11;7(8):e014505
pubmed: 28801389

Auteurs

Laura Inhestern (L)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Mona L Peikert (ML)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Konstantin A Krauth (KA)

Department of Pediatrics, Pediatric Hematology & Oncology, Klinik Bad Oexen, Bad Oeynhausen, Germany.

Gabriele Escherich (G)

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Stefan Rutkowski (S)

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Daniela Kandels (D)

Swabian Children's Cancer Center, University Hospital Augsburg, Augsburg, Germany.

Corinna Bergelt (C)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH